Cargando…
CLDN6 promotes chemoresistance through GSTP1 in human breast cancer
BACKGROUND: Claudin-6 (CLDN6), a member of CLDN family and a key component of tight junction, has been reported to function as a tumor suppressor in breast cancer. However, whether CLDN6 plays any role in breast cancer chemoresistance remains unclear. In this study, we investigated the role of CLDN6...
Autores principales: | Yang, Minlan, Li, Yanru, Shen, Xiangfeng, Ruan, Yang, Lu, Yan, Jin, Xiangshu, Song, Peiye, Guo, Yantong, Zhang, Xiaoli, Qu, Huinan, Shao, Yijia, Quan, Chengshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678781/ https://www.ncbi.nlm.nih.gov/pubmed/29116019 http://dx.doi.org/10.1186/s13046-017-0627-9 |
Ejemplares similares
-
SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells
por: Lu, Yan, et al.
Publicado: (2017) -
Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy
por: Song, Peiye, et al.
Publicado: (2019) -
A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis
por: Jia, Yiyang, et al.
Publicado: (2020) -
ERα is required for suppressing OCT4‐induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis
por: Jin, Xiangshu, et al.
Publicado: (2019) -
CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers
por: Qu, Huinan, et al.
Publicado: (2021)